Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b201ffd2a1990c952659e9c7e189df |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1128 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-02 |
filingDate |
2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56fb7c7abe021f2d4f0024817cb2e776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e0dc37687ecdf16d6f7a7254bed823 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03407ee8bd2af7f5f325e35d8777b502 |
publicationDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021121181-A1 |
titleOfInvention |
Device and method of creating a fluid containment field for administering therapeutics to a nerve |
abstract |
A severed nerve may be surgically rejoined and severed axons fused via sequential administrations of solutions. The solutions may include a priming solution comprising methylene blue in a Ca2+-free saline solution, a fusion solution comprising about 50% (w/w) PEG, and a sealing solution comprising Ca2+-containing saline. The PEG fusion solution may be applied in a nerve treatment device configured to isolate the injured segment of the nerve. The device may include a containment chamber for creating a fluid containment field around the anastomosis. The device may have slits, slots, and/or apertures in opposing endwalls of the device designed to receive the nerve. The device may have an open bath configuration or may include separable lower and upper bodies to create a closed bath configuration. The device may include one or more fluid ports in fluid communication with the containment chamber for introducing and/or removing fluid. |
priorityDate |
2017-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |